Historical record - last NADAC effective date: 1/1/2020
Product Information
PRISTIQ ER 50 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $13.2311 per EA under NDC 00008121150. Its NADAC has been published 332 times since Nov 28, 2013.
FDA first approved this application on Feb 29, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the desvenlafaxine succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
NDC
00008121150
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
1/1/2020
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA021992FDA Approved
2/29/2008
TE Code
AB
On Market Since
5/1/2008
Pharmacological Classes
Price Statistics
The NADAC for PRISTIQ ER 50 MG TABLET has been published 332 times since Nov 28, 2013, and over the history we have for it it has risen 130.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.2311 per EA |
|---|---|
| All-time high | $13.2311 (Apr 1, 2020) |
| All-time low | $5.7410 (Nov 28, 2013) |
| Median price | $10.2079 |
| Average price | $9.9702 |
| Largest weekly change | +9.4% (Jan 8, 2014) |
| Weeks tracked | 332 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+130.5%
Last surveyed Apr 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRISTIQ ER 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRISTIQ ER 50 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $13.2311 per EA (NDC 00008121150), effective Apr 1, 2020.
How has the price of PRISTIQ ER 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRISTIQ ER 50 MG TABLET has risen 130.5%. It has been tracked across 332 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PRISTIQ ER 50 MG TABLET?
Since Nov 28, 2013, the NADAC for PRISTIQ ER 50 MG TABLET has ranged from a low of $5.7410 (Nov 28, 2013) to a high of $13.2311 (Apr 1, 2020), with a median of $10.2079 per EA.
Are there cheaper alternatives to PRISTIQ ER 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PRISTIQ ER 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRISTIQ ER 50 MG TABLET?
PRISTIQ ER 50 MG TABLET (NDC 00008121150) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.